PR Newswire·Nov 12, 2026, 8:01 AM ET

NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approximately 66% Reduction in Net Loss

NXPL

NextPlat Corp reported third quarter 2026 consolidated revenue of approximately $10.5 million, a decrease from $13.8 million in the prior year period due to lower reimbursement rates & retail prescription volumes.
Higher margin 340B prescription volumes grew nearly 72% year-over-year, driving a 300% increase in pharmacy contract revenue to approximately $2.4 million.
Gross margin improved significantly to 35.0% overall, with the Healthcare Operations segment margin rising to 41% from 18% in the third quarter of 2025.
Net loss attributable to common stockholders decreased 66% to approximately $0.7 million ($0.28 per share) compared to $2.2 million in the same period last year.
E-commerce revenue increased 3% to approximately $3.8 million, driven by record high-margin airtime contract revenue & expanded international sales channels including a partnership with Decathlon.
The Company expanded its pharmacy footprint by acquiring Scott's pharmacy in the Pensacola area & opening a new location in Jacksonville.
Operating expenses decreased to approximately $4.5 million from $4.9 million, primarily due to lower salaries & reduced litigation settlement losses.
The Company ended the quarter with approximately $11.2 million in cash, $13.5 million in working capital, & no material unsecured debt.
A new nationwide medication fulfillment website is scheduled to launch in the fourth quarter to expand PharmcoRx reach beyond Florida.
Three new 340B services contracts were added during the quarter, with onboarding expected to contribute to increased revenue in early 2027.

Company: NextPlat Corp.
Keywords: NextPlat Corp.